451 related articles for article (PubMed ID: 17133458)
1. Hyponatremia in cirrhosis: Results of a patient population survey.
Angeli P; Wong F; Watson H; Ginès P;
Hepatology; 2006 Dec; 44(6):1535-42. PubMed ID: 17133458
[TBL] [Abstract][Full Text] [Related]
2. Serum sodium predicts prognosis in critically ill cirrhotic patients.
Jenq CC; Tsai MH; Tian YC; Chang MY; Lin CY; Lien JM; Chen YC; Fang JT; Chen PC; Yang CW
J Clin Gastroenterol; 2010 Mar; 44(3):220-6. PubMed ID: 19636261
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration.
Guevara M; Baccaro ME; Ríos J; Martín-Llahí M; Uriz J; Ruiz del Arbol L; Planas R; Monescillo A; Guarner C; Crespo J; Bañares R; Arroyo V; Ginès P
Liver Int; 2010 Sep; 30(8):1137-42. PubMed ID: 20602681
[TBL] [Abstract][Full Text] [Related]
4. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites.
Sersté T; Gustot T; Rautou PE; Francoz C; Njimi H; Durand F; Valla D; Lebrec D; Moreau R
J Hepatol; 2012 Aug; 57(2):274-80. PubMed ID: 22521353
[TBL] [Abstract][Full Text] [Related]
5. Frequency of hyponatraemia and its influence on liver cirrhosis-related complications.
Shaikh S; Mal G; Khalid S; Baloch GH; Akbar Y
J Pak Med Assoc; 2010 Feb; 60(2):116-20. PubMed ID: 20209698
[TBL] [Abstract][Full Text] [Related]
6. The association between the serum sodium level and the severity of complications in liver cirrhosis.
Kim JH; Lee JS; Lee SH; Bae WK; Kim NH; Kim KA; Moon YS
Korean J Intern Med; 2009 Jun; 24(2):106-12. PubMed ID: 19543488
[TBL] [Abstract][Full Text] [Related]
7. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
[TBL] [Abstract][Full Text] [Related]
8. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.
Vila MC; Coll S; Solà R; Andreu M; Gana J; Marquez J
Am J Gastroenterol; 1999 Aug; 94(8):2219-23. PubMed ID: 10445553
[TBL] [Abstract][Full Text] [Related]
9. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.
Cárdenas A; Ginès P; Marotta P; Czerwiec F; Oyuang J; Guevara M; Afdhal NH
J Hepatol; 2012 Mar; 56(3):571-8. PubMed ID: 22027579
[TBL] [Abstract][Full Text] [Related]
10. Hyponatremia in cirrhosis: Risk factors and prognostic value.
Ennaifer R; Cheikh M; Romdhane H; El Elj R; Ben Nejma H; Bougassas W; Bel Hadj N
Tunis Med; 2016 May; 94(5):401-405. PubMed ID: 27801493
[TBL] [Abstract][Full Text] [Related]
11. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
Guevara M; Baccaro ME; Torre A; Gómez-Ansón B; Ríos J; Torres F; Rami L; Monté-Rubio GC; Martín-Llahí M; Arroyo V; Ginès P
Am J Gastroenterol; 2009 Jun; 104(6):1382-9. PubMed ID: 19455124
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
Akriviadis EA; Ervin MG; Cominelli F; Fisher DA; Reynolds TB
Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977
[TBL] [Abstract][Full Text] [Related]
13. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
Gerbes AL; Gülberg V; Ginès P; Decaux G; Gross P; Gandjini H; Djian J;
Gastroenterology; 2003 Apr; 124(4):933-9. PubMed ID: 12671890
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous bacterial peritonitis and bacterascites prevalence in asymptomatic cirrhotic outpatients undergoing large-volume paracentesis.
Castellote J; Girbau A; Maisterra S; Charhi N; Ballester R; Xiol X
J Gastroenterol Hepatol; 2008 Feb; 23(2):256-9. PubMed ID: 17683477
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
Ackermann D
Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
[TBL] [Abstract][Full Text] [Related]
18. [Hyponatremia as a possible mortality factor in cirrhotic patients hospitalised in the Guillermo Almenara Irigoyen State Hospital, 2003- 2005].
Rafael Valdivia L; Ferrandiz Quiroz J
Rev Gastroenterol Peru; 2007; 27(1):37-46. PubMed ID: 17431435
[TBL] [Abstract][Full Text] [Related]
19. Correlation of hyponatremia with hepatic encephalopathy and severity of liver disease.
Qureshi MO; Khokhar N; Saleem A; Niazi TK
J Coll Physicians Surg Pak; 2014 Feb; 24(2):135-7. PubMed ID: 24491011
[TBL] [Abstract][Full Text] [Related]
20. [Hyponatremia in patients with ascites complicating liver cirrhosis].
Xu Z; Jiang ZH
Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):628-30, 658-9. PubMed ID: 1582343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
